132 related articles for article (PubMed ID: 16419427)
1. Bilateral uveitis manifesting as a complication of chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Wertheim M; Rosenbaum JT
Ocul Immunol Inflamm; 2005; 13(5):403-4. PubMed ID: 16419427
[TBL] [Abstract][Full Text] [Related]
2. Anterior uveitis: a manifestation of graft-versus-host disease.
Hettinga YM; Verdonck LF; Fijnheer R; Rijkers GT; Rothova A
Ophthalmology; 2007 Apr; 114(4):794-7. PubMed ID: 17187864
[TBL] [Abstract][Full Text] [Related]
3. Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation.
Liedtke W; Quabeck K; Beelen DW; Straeten V; Schaefer UW
J Neurol Sci; 1994 Aug; 125(1):110-1. PubMed ID: 7964881
[TBL] [Abstract][Full Text] [Related]
4. Late effects of chronic graft-vs.-host disease in minor salivary glands.
Alborghetti MR; Corrêa ME; Adam RL; Metze K; Coracin FL; de Souza CA; Cintra ML
J Oral Pathol Med; 2005 Sep; 34(8):486-93. PubMed ID: 16091116
[TBL] [Abstract][Full Text] [Related]
5. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
Dilek I; Demirer T; Ustün C; Arat M; Koç H; Beksaç M; Erdi H; Anadolu R; Ozcan M; Ilhan O; Akan H
Bone Marrow Transplant; 1998 Jun; 21(11):1159-61. PubMed ID: 9645582
[TBL] [Abstract][Full Text] [Related]
6. 15-Deoxyspergualin controls cyclosporin- and steroid-resistant intestinal acute graft-versus-host disease after allogeneic bone marrow transplantation.
Kasai M; Higa T; Naohara T; Masauzi N; Watanabe M; Matsuura A; Ohizumi H; Tanaka J; Morii K; Kiyama Y
Bone Marrow Transplant; 1994 Aug; 14(2):315-7. PubMed ID: 7994248
[TBL] [Abstract][Full Text] [Related]
7. Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal.
Oliveira JS; Bahia D; Franco M; Balda C; Stella S; Kerbauy J
Bone Marrow Transplant; 1999 Jan; 23(1):99-101. PubMed ID: 10037059
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of skin biopsies in the diagnosis and management of graft-vs-host disease in early postallogeneic bone marrow transplantation.
Zhou Y; Barnett MJ; Rivers JK
Arch Dermatol; 2000 Jun; 136(6):717-21. PubMed ID: 10871932
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease.
Arora M; Wagner JE; Davies SM; Blazar BR; Defor T; Enright H; Miller WJ; Weisdorf DF
Biol Blood Marrow Transplant; 2001; 7(5):265-73. PubMed ID: 11400948
[TBL] [Abstract][Full Text] [Related]
10. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E
Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
[TBL] [Abstract][Full Text] [Related]
11. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
[TBL] [Abstract][Full Text] [Related]
12. Atypical acute graft-versus-host disease.
Shin J; Hong W; Song H; Choi G; Kim YC
Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.
Ross M; Schmidt GM; Niland JC; Amylon MD; Dagis AC; Long GD; Nademanee AP; Negrin RS; O'Donnell MR; Parker PM; Smith EP; Snyder DS; Stein AS; Wong RM; Forman SJ; Blume KG; Chao NJ
Biol Blood Marrow Transplant; 1999; 5(5):285-91. PubMed ID: 10534058
[TBL] [Abstract][Full Text] [Related]
14. Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease.
Leiter U; Kaskel P; Krähn G; Gottlöber P; Bunjes D; Peter RU; Kerscher M
Photodermatol Photoimmunol Photomed; 2002 Aug; 18(4):183-90. PubMed ID: 12390673
[TBL] [Abstract][Full Text] [Related]
15. A single course of remission reinduction chemotherapy for acute myelogenous leukemia relapsing after allogeneic bone marrow transplantation is complicated by graft-versus-host disease and followed by sustained complete remission.
Vandenberghe P; Verhoef GE; Emonds MP; Demuynck H; Zachée P; De Wolf-Peeters C; Decorte R; Cassiman JJ; Boogaerts MA
Leukemia; 1997 Oct; 11(10):1775-8. PubMed ID: 9324300
[TBL] [Abstract][Full Text] [Related]
16. Pleuroparenchymal fibroelastosis as a series of airway complications associated with chronic graft-versus-host disease following allogeneic bone marrow transplantation.
Fujikura Y; Kanoh S; Kouzaki Y; Hara Y; Matsubara O; Kawana A
Intern Med; 2014; 53(1):43-6. PubMed ID: 24390527
[TBL] [Abstract][Full Text] [Related]
17. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.
Grosskreutz C; Ross V; Scigliano E; Fruchtman S; Isola L
Biol Blood Marrow Transplant; 2003 Jul; 9(7):453-9. PubMed ID: 12869959
[TBL] [Abstract][Full Text] [Related]
18. Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.
Hwang WY; Goh YT; Tan CH; How GF; Tan HC
Bone Marrow Transplant; 2000 Jan; 25(2):205-7. PubMed ID: 10673682
[TBL] [Abstract][Full Text] [Related]
19. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
[TBL] [Abstract][Full Text] [Related]
20. Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gluckman E; Reiffers J; Vernant JP; Jouet JP; Harrousseau JL; Fiere D; Bacigalupo A; Frassoni F; Gorin NC
Bone Marrow Transplant; 1996 Nov; 18(5):921-9. PubMed ID: 8932846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
